Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-080293
Filing Date
2025-04-14
Accepted
2025-04-14 17:17:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d869592d424b5.htm 424B5 493413
2 GRAPHIC g869592g13a01.jpg GRAPHIC 31346
3 GRAPHIC g869592g13a02.jpg GRAPHIC 36113
  Complete submission text file 0001193125-25-080293.txt   586882
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271786 | Film No.: 25836791
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)